Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells

Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, Köhler B, Dörfler A, Grieshaber Bouyer R, Mackensen A, Schett G (2024)

Publication Type: Journal article

Publication year: 2024

Journal

The Lancet Elsevier

Book Volume: 404

Pages Range: 2158-2160

Journal Issue: 10468

DOI: 10.1016/S0140-6736(24)02265-7

Authors with CRIS profile

Melanie Hagen Department of Medicine 3 – Rheumatology and Immunology Fabian Müller Professur für CAR-T-Zell-Therapie Silvia Spörl Department of Medicine 5 – Haematology and Oncology Simon Völkl Department of Medicine 5 – Haematology and Oncology Arnd Dörfler Department of Neuroradiology Ricardo Grieshaber Bouyer Professur für Klinische Systemimmunologie Andreas Mackensen Lehrstuhl für Innere Medizin V Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Städtisches Klinikum Karlsruhe DE Germany (DE)

How to cite

APA:

Hagen, M., Müller, F., Wirsching, A., Kharboutli, S., Spörl, S., Aigner, M.,... Schett, G. (2024). Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells. The Lancet, 404(10468), 2158-2160. https://doi.org/10.1016/S0140-6736(24)02265-7

MLA:

Hagen, Melanie, et al. "Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells." The Lancet 404.10468 (2024): 2158-2160.

BibTeX: Download